RxDoctor Payments Data

Lila Peckham Wichman, APRN

Psychiatric/Mental Health · Lenexa, KSNPI 1366409427

Payments from drug & device makers

$966in general payments, 2019–2025

Across 52 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$232
  • Alkermes, Inc.$148
  • Johnson & Johnson$140
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$122
  • Otsuka America Pharmaceutical, Inc.$119
  • Teva Pharmaceuticals USA, Inc.$60
  • plus $145 from 5 others

What the payments were for

  • Food & beverage$91995%
  • Education$475%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$966 in reported general payments places this provider in the 60th percentile of 404 psychiatric/mental health providers in Kansas.

See all psychiatric/mental health providers in Kansas

Medicare billing

Part B allowed, 2024
$5,201
Medicare patients
30
Services billed
90

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LatudaLurasidone Hcl26$44,147
Abilify MaintenaAripiprazole12$38,411
Risperdal ConstaRisperidone Microspheres13$18,147
Lurasidone Hcl35$15,271
TrintellixVortioxetine Hydrobromide13$6,250
Aripiprazole94$4,431
Ziprasidone Hcl26$2,280
Asenapine Maleate12$1,805
Desvenlafaxine Succinate ErDesvenlafaxine Succinate37$932
Quetiapine Fumarate53$927
Olanzapine54$922
Buspirone Hcl45$868
Clonazepam89$792
Trazodone Hcl109$746
Haloperidol20$741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sunovion Pharmaceuticals Inc.Latuda$50$44,14726 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$119$38,41112 claims
Johnson & JohnsonRisperdal Consta$140$18,14713 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$54$6,25013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 404 psychiatric/mental health providers in Kansas.

Other psychiatric/mental health in Lenexa

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →